A detailed history of Principal Securities, Inc. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Principal Securities, Inc. holds 187 shares of BIO stock, worth $62,848. This represents 0.0% of its overall portfolio holdings.

Number of Shares
187
Previous 186 0.54%
Holding current value
$62,848
Previous $50.8 Million 23.17%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$263.97 - $344.64 $263 - $344
1 Added 0.54%
187 $62.6 Million
Q2 2024

Jul 31, 2024

BUY
$268.26 - $339.48 $4,560 - $5,771
17 Added 10.06%
186 $50.8 Million
Q1 2024

May 10, 2024

BUY
$304.11 - $351.99 $12,468 - $14,431
41 Added 32.03%
169 $58.5 Million
Q4 2023

Feb 07, 2024

BUY
$269.37 - $365.04 $34,479 - $46,725
128 New
128 $41.3 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.28B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Principal Securities, Inc. Portfolio

Follow Principal Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Principal Securities, Inc. with notifications on news.